Provista Diagnostics
Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test
Todos Medical acquired the subsidiary, Provista Diagnostics, in early 2021 from Ascenda Biosciences for $7.5 million in cash and stock.
Todos Medical, Fosun Pharma Ink Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Test
Todos said it plans to offer the GenScript neutralizing antibody kit as a testing service to CLIA-certified laboratories and healthcare professionals.
Todos Medical to Acquire Provista Diagnostics
Provista is developing and commercializing the Videssa blood test for breast cancer, which has been clinically validated for early detection.
Ascenda Biosciences Acquires Provista Diagnostics
As part of the deal, Alpharetta, Georgia-based Ascenda acquired Provista's Videssa Breast test, a blood-based proteomic test for aiding assessment of indeterminate mammograms.
While studies conducted by the company have found the test could significantly reduce unnecessary biopsies, sales have been modest to date.